Carregant...
The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease
BACKGROUND: Better treatment during early stages of chronic kidney disease (CKD) may slow progression to end-stage renal disease and decrease associated complications and medical costs. Achieving early treatment of CKD is challenging, however, because a large fraction of persons with CKD are unaware...
Guardat en:
| Publicat a: | BMC Nephrol |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5347833/ https://ncbi.nlm.nih.gov/pubmed/28288579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-017-0497-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|